Whooping Cough in a Non-immunized Infant: Clinical Case Report

Main Article Content

Diana P. Lara-Ojeda
Claudia Lizama-Rubio
María del Mar Lugo-Bastarrachea
Silvia Rebeca Puga-Chan
Marco A. Peraza-Peniche
Nina Méndez-Domínguez

Abstract

DOI: 10.1016/j.rcpe.2016.10.001


Introduction


Respiratory tract infections are a common cause of infant morbidity, and even mortality.


Case report


A two-month old female was taken to the Emergency Department after she suddenly developed dyspnoea and a paroxysmal, spasmodic, cyanosing cough. Her vaccination scheme was incomplete and she had contact with her twin sister, who had an infection probably caused by Bordetella pertussis. The discharge diagnosis was bronchiolitis. She was re-admitted to hospital a few days later with an exacerbation of her dyspnoea.


Discussion


This case highlights the importance of following the clinical practice guidelines and the standard procedures for the diagnosis of B. pertussis, while the epidemiological context of patients should always be considered. It is important to correctly identify the aetiological agent, as the specific treatment is based on the aetiology, and both of them determine the prognosis of the patients. 

Downloads

Download data is not yet available.

Article Details

How to Cite
Lara-Ojeda, D. P., Lizama-Rubio, C., Lugo-Bastarrachea, M. del M., Puga-Chan, S. R., Peraza-Peniche, M. A., & Méndez-Domínguez, N. (2016). Whooping Cough in a Non-immunized Infant: Clinical Case Report. Pediatría, 49(4), 118–121. Retrieved from https://revistapediatria.org/rp/article/view/9
Section
Case report

References

1. G. Durán Bolaños,C. Monge Castro,G. Herrera Mora,M. Gamboa Montero Tosferina, una enfermedad prevalente Med Legal Costa Rica., 30 (2013), pp. 123-128

2. Bordetella and whooping cough,


3. G.F. Pérez-Pérez,T. Rojas-Mendoza,D.A. Cabrera-Gaytán,C. Grajales-Muñiz Panorama epidemiológico de la tosferina 19 años de estudio epidemiológico en el Instituto Mexicano del Seguro Social Rev Med IMSS., 53 (2015), pp. 164-170 Medline

4. F. Gao,J.C. Mahoney,E.R. Daly,W. Lamothe,D. Tullo,C. Bean Evaluation of a multitarget real-time PCR assay for detection of Bordetella species during a pertussis outbreak in New Hampshire in 2011 J Clin Microbiol., 52 (2014), pp. 302 306 http://dx.doi.org/10.1128/JCM.01656-13 Medline


5. K. Kamachi,S. Yoshino,C. Katsukawa,N. Otsuka,Y. Hiramatsu,K. Shibayama Laboratory-based surveillance of pertussis using multitarget real-time PCR in Japan: evidence for Bordetella pertussis infection in preteens and teens N Microbes N Infect., 8 (2015), pp. 70-74

6. Lineamientos para la vigilancia epidemiológica de tos ferina y síndrome coqueluchoide Dirección General de Epidemiología, Secretaria de Salud, (2015)pp. 11-30


7. F. Giménez-Sánchez,E. Cobos-Carrascosa,M. Sánchez-Forte,M.Á. López-Sánchez,Y. González-Jiménez,E. Azor-Martínez Diferencias clínicas y epidemiológicas entre las infecciones por Bordetella pertussis y por virus respiratorio sincitial en lactantes: estudio de casos controles emparejados Enferm Infec Microbiol Clin., 32 (2014), pp. 359-362

8. S.M. Altunaiji,R.H. Kukuruzovic,N.C. Curtis,J. Massie Cochrane Review Antibiotics for whooping cough (pertussis) Cochrane Database Syst Rev., (2007), pp. CD004404

9. Ravaglia C, Poletti V. Recent advances in the management of acute bronchiolitis. F1000prime reports. 2014;6.

10. T. Tapiainen,J. Aittoniemi,J. Immonen,H. Jylkkä,T. Meinander,K. Nuolivirta Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children Acta Paediatr., 105 (2016), pp. 44-49 http://dx.doi.org/10.1111/apa.13162 Medline

11. R. Umoren,F. Odey,M.M. Meremikwu Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age Cochrane Database System Rev., (2007), pp. CD006435

12. S.L. Ralston,A.S. Lieberthal,H.C. Meissner,B.K. Alverson,J.E. Baley,A.M. Gadomski Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis Pediatrics., 134 (2014), pp. e1474-e1502 http://dx.doi.org/10.1542/peds.2014-2742 Medline

13. Nebot MS, Teruel GC, Cubells CL, Sabadell ME, Fernández JP, editores. Guía de práctica clínica sobre la bronquiolitis aguda: recomendaciones para la práctica clínica. An Pediatr (Barc). 2010;73:208.e1–10.

14. C. Dotres Martínez,D. Vega Mendoza,G. Toraño Peraza,M. Álvarez Carmenate,A. Broche Morera Síndrome coqueluchoide y tos ferina Rev Cubana Med Gen Integral., 28 (2012), pp. 725-734

15. T. Tiwari,T.V. Murphy,J. Moran Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis MMWR Recomm Rep., 54 (2005), pp. 1-16 Medline

16. H. Mejía Salas Coqueluche en niños Rev Bol Ped., 52 (2013), pp. 22-26

17. World Health Organization recommended standards for surveillance of selected vaccine-preventable diseases. Vaccine Assessment and Monitoring team WHO, (2008)

18. F.A. Moraga-Llop,M. Campins-Martí Vacuna de la tos ferina. Reemergencia de la enfermedad y nuevas estrategias de vacunación Enferm Infec Microbiol Clin., 33 (2015), pp. 190-196

19. B.A. Halperin,S.A. Halperin The reemergence of pertussis and infant deaths: is it time to immunize pregnant women Fut Microbiol., 6 (2011), pp. 367-369

20. M.H. Sawyer,S.S. Long Tdap in every pregnancy: circling the wagons around the newborn Pediatrics., 135 (2015), pp. e1483-e1484 http://dx.doi.org/10.1542/peds.2015-0770 Medline

21. F.R. Mooi,S.C. De Greeff The case for maternal vaccination against pertussis Lancet Infect Dis., 7 (2007), pp. 614-624 http://dx.doi.org/10.1016/S1473-3099(07)70113-5 Medline

22. A. Bechini,E. Tiscione,S. Boccalini,M. Levi,P. Bonanni Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations Vaccine., 30 (2012), pp. 5179-5190 http://dx.doi.org/10.1016/j.vaccine.2012.06.005 Medline